NO20025392D0 - 2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)- trienderivater og deres biologiske aktivitet - Google Patents

2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)- trienderivater og deres biologiske aktivitet

Info

Publication number
NO20025392D0
NO20025392D0 NO20025392A NO20025392A NO20025392D0 NO 20025392 D0 NO20025392 D0 NO 20025392D0 NO 20025392 A NO20025392 A NO 20025392A NO 20025392 A NO20025392 A NO 20025392A NO 20025392 D0 NO20025392 D0 NO 20025392D0
Authority
NO
Norway
Prior art keywords
group
triene
chola
carboxaldehyde
hydrogen
Prior art date
Application number
NO20025392A
Other languages
English (en)
Other versions
NO20025392L (no
NO323857B1 (no
Inventor
Robert Henry Hesse
Sundara Katugam Srinivas Setty
Maurice Murdoch Pechet
Michael Gile
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of NO20025392D0 publication Critical patent/NO20025392D0/no
Publication of NO20025392L publication Critical patent/NO20025392L/no
Publication of NO323857B1 publication Critical patent/NO323857B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20025392A 2000-05-11 2002-11-11 2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)-trienderivater og deres biologiske aktivitet NO323857B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20346200P 2000-05-11 2000-05-11
PCT/GB2001/002103 WO2001085755A1 (en) 2000-05-11 2001-05-11 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity

Publications (3)

Publication Number Publication Date
NO20025392D0 true NO20025392D0 (no) 2002-11-11
NO20025392L NO20025392L (no) 2003-01-09
NO323857B1 NO323857B1 (no) 2007-07-16

Family

ID=22754111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025392A NO323857B1 (no) 2000-05-11 2002-11-11 2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)-trienderivater og deres biologiske aktivitet

Country Status (17)

Country Link
EP (1) EP1287017B1 (no)
JP (1) JP2003532737A (no)
KR (1) KR100740354B1 (no)
CN (1) CN100338088C (no)
AT (1) ATE301130T1 (no)
AU (1) AU784563B2 (no)
CA (1) CA2408751A1 (no)
CZ (1) CZ298835B6 (no)
DE (1) DE60112438T2 (no)
DK (1) DK1287017T3 (no)
ES (1) ES2247102T3 (no)
HK (1) HK1053843A1 (no)
IL (2) IL152728A0 (no)
NO (1) NO323857B1 (no)
NZ (1) NZ523042A (no)
WO (1) WO2001085755A1 (no)
ZA (1) ZA200209060B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
WO2002042319A2 (en) * 2000-11-27 2002-05-30 Entremed, Inc. 2-substituted estrogens as antiangiogenic agents
WO2002092100A1 (en) * 2001-05-11 2002-11-21 Marsden, John, Christopher 17-(c(ch3) (ch2) o-3c (r4, r5) n (r6, r7))-substituted 19-nor-pregna-1, 3, 5(10)-triene derivatives and their medical use
CA2520142C (en) 2003-03-24 2011-01-04 Sterix Limited Oestrogen derivatives as inhibitors of steroid sulphatase
JP2007529426A (ja) 2004-03-12 2007-10-25 エントレメッド インコーポレイテッド 抗血管新生薬
AU2007227256B2 (en) 2006-03-20 2012-10-04 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562260A (en) * 1965-08-23 1971-02-09 Ormonoterapia Richter Spa 2-carbonyl-estratrienes and method of their preparation
JPS54112580A (en) * 1978-02-23 1979-09-03 Nec Corp Electroless discharge lamp
JPS54112850A (en) * 1978-02-23 1979-09-04 Mitsubishi Chem Ind Ltd Steroid derivative and its preparation
JPS54112849A (en) * 1978-02-23 1979-09-04 Mitsubishi Chem Ind Ltd Preparation of steroid derivative
JPS54117454A (en) * 1978-03-02 1979-09-12 Mitsubishi Chem Ind Ltd Acylsteroid derivative
JPS54117455A (en) * 1978-03-02 1979-09-12 Mitsubishi Chem Ind Ltd Novel 19-norsteroid derivative
JPS54117456A (en) * 1978-03-02 1979-09-12 Mitsubishi Chem Ind Ltd Alkoxysteroid derivative
GB9804861D0 (en) * 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
GB9910934D0 (en) * 1999-05-11 1999-07-14 Res Inst Medicine Chem Chemical compounds

Also Published As

Publication number Publication date
ZA200209060B (en) 2004-02-09
IL152728A0 (en) 2003-06-24
NZ523042A (en) 2004-05-28
DE60112438T2 (de) 2006-06-08
IL152728A (en) 2007-02-11
CZ298835B6 (cs) 2008-02-20
KR20030031899A (ko) 2003-04-23
HK1053843A1 (en) 2003-11-07
DE60112438D1 (de) 2005-09-08
NO20025392L (no) 2003-01-09
KR100740354B1 (ko) 2007-07-26
AU784563B2 (en) 2006-05-04
JP2003532737A (ja) 2003-11-05
NO323857B1 (no) 2007-07-16
AU5498401A (en) 2001-11-20
DK1287017T3 (da) 2005-12-05
ES2247102T3 (es) 2006-03-01
EP1287017B1 (en) 2005-08-03
ATE301130T1 (de) 2005-08-15
CZ20023719A3 (cs) 2003-04-16
CN1444597A (zh) 2003-09-24
CA2408751A1 (en) 2001-11-15
EP1287017A1 (en) 2003-03-05
CN100338088C (zh) 2007-09-19
WO2001085755A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
NO20015520D0 (no) Steroidforbindelser med en C17-alkyl sidekjede og en aromatisk A-ring for anvendelse i terapi
BR0113064A (pt) Compostos que atuam como ligandos de receptor de melanocortina
MXPA03001072A (es) El uso de bencilidenaminoguanidinas e hidroxiguanidinas como ligandos de receptor de melanocortina.
NO20025392D0 (no) 2-substituerte pregna-1,3-5(10)-trien og chola-1,3,5(10)- trienderivater og deres biologiske aktivitet
BG101190A (en) Pharmaceutical preparation containing estra-1,3,5/10/-triene derivatives
ATE554225T1 (de) Tissue für haushaltsgebrauch
RS49588B (sr) Derivati benzopirana koji poseduju leukotrien-antagonističko dejstvo
TR199801415T2 (xx) Se�ici taksanlar,bunlar� haz�rlamak i�in y�ntem ve bunlar�n ila� olarak kullan�m�.
KR880012634A (ko) C_17-20리아제 억제제로서 유용한 17β-(사이클로프로필옥시)안드로스트-5-엔-3β-올 및 관련 화합물
ATE425803T1 (de) Entschaumerzusammensetzung fur wassrige zusammensetzungen
ES8407322A1 (es) Procedimiento para la preparacion de 7 -aciltio-15,16-metilen-3-oxo-17 -pregna-1,4-dien-21,17-carbolactonas
PT934745E (pt) Utilizacao de derivados de androsterona para a inibicao da ligacao do adn de ap-1 e a proliferacao do musculo liso das vias respiratorias
DE602007007218D1 (de) Neue zuckerderivate, verfahren für ihre zubereitung und ihre verwendung als oberflächenaktive mittel
SE9701912D0 (sv) Pharmaceutical composition and use thereof
ATE199159T1 (de) 17-difluormethylen-estratriene
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
CO5160305A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica
DK1137660T3 (da) 22S-hydroxycholesta-8,14-dienderivater med meioseregulerende aktivitet
DK1192191T3 (da) Fremgangsmåde til fremstilling af kondensationsforbindelser
YU60496A (sh) Novi 16,17-seko-,16-keto-i 16-oksimino-17- supstituisani steroidi estratrienske i androstenske serije sa biološkom aktivnošću
KR870008512A (ko) 식물 생장 조절용 조성물
RS20060416A (en) Substituted 16-ketosteroids of the estratriene and androstene series with biological activity
HUP0302020A2 (hu) 2-Szubsztituált pregna-1,3,5,(10)-trién- és kola-1,3,5(10)-trién-származékok, eljárás elżállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények